OXPHOS mutations and neurodegeneration

Werner J.H. Koopman*, Felix Distelmaier, Jan A.M. Smeitink, Peter H.G.M. Willems

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

217 Citations (Scopus)

Abstract

Mitochondrial oxidative phosphorylation (OXPHOS) sustains organelle function and plays a central role in cellular energy metabolism. The OXPHOS system consists of 5 multisubunit complexes (CI-CV) that are built up of 92 different structural proteins encoded by the nuclear (nDNA) and mitochondrial DNA (mtDNA). Biogenesis of a functional OXPHOS system further requires the assistance of nDNA-encoded OXPHOS assembly factors, of which 35 are currently identified. In humans, mutations in both structural and assembly genes and in genes involved in mtDNA maintenance, replication, transcription, and translation induce 'primary' OXPHOS disorders that are associated with neurodegenerative diseases including Leigh syndrome (LS), which is probably the most classical OXPHOS disease during early childhood. Here, we present the current insights regarding function, biogenesis, regulation, and supramolecular architecture of the OXPHOS system, as well as its genetic origin. Next, we provide an inventory of OXPHOS structural and assembly genes which, when mutated, induce human neurodegenerative disorders. Finally, we discuss the consequences of mutations in OXPHOS structural and assembly genes at the single cell level and how this information has advanced our understanding of the role of OXPHOS dysfunction in neurodegeneration.

Original languageEnglish
Pages (from-to)9-29
Number of pages21
JournalEMBO Journal
Volume32
Issue number1
DOIs
Publication statusPublished - 9 Jan 2013
Externally publishedYes

Keywords

  • mitochondria
  • neurodegeneration
  • OXPHOS

Fingerprint

Dive into the research topics of 'OXPHOS mutations and neurodegeneration'. Together they form a unique fingerprint.

Cite this